Sanofi announced the appointment of Dr. Gary J. Nabel, M.D., Ph.D., to Chairman of the Strategic Development and Scientific Advisory Council (SDSAC). Dr. Nabel, currently Senior Vice President, Chief Scientific Officer and Deputy to Dr. Elias Zerhouni, President, Global R&D, will succeed Dr. Richard Klausner. As part of his key responsibilities as Chief Scientific Officer for global R&D, Dr. Nabel will direct the activities of the Council, including selection, appointment and evaluation of advisers.